CV DEATH HAS A NEW OPPONENT
CV DEATH HAS A NEW OPPONENT

Empagliflozin has consistent CV benefits in the full spectrum of HF

Document ID: PC-PH-104582

27/03/2023

Author: Boehringer Ingelheim

Video Player is loading.
Current Time 0:00
Duration 2:29
Loaded: 0.00%
Stream Type LIVE
Remaining Time 2:29
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Related content

     
    PC-PH-104582
    Production date: March 2022